Wozniak, K.; Gloc, E.; Morawiec, Z.; Blasiak, J.
(Experimental Oncology, 2008)
We have previously shown that amifostine differentially modulated the DNA-damaging action of idarubicin in normal and cancer cells and that the presence of p53 protein and oncogenic tyrosine kinases might play a role in ...